News
13h
TipRanks on MSNPfizer’s Bold Clinical Trials Could Boost Stock PerformancePfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer Inc. is actively advancing its ...
Three Fool.com contributors have identified no-brainer stocks to buy for under $100 right now. Here's why they picked two big ...
Lantheus Holdings Inc. (NASDAQ: LNTH) is one of the most undervalued US stocks according to analysts. On June 20, Lantheus ...
1d
24/7 Wall St. on MSN5 Recession-Proof Dividend Stocks With Yields Over 6%When the economy is barreling toward a recession, investors' first line of defense might be to abandon ship altogether. After ...
Dr. Todd Ellerin, Vice Chair of Department of Medicine of South Shore Health discusses the new FDA warning regarding Pfizer and Moderna COVID-19 vaccines. The FDA is expanding warnings on Pfizer and ...
On June 26, Pfizer announced positive topline results from its Phase 3 BASIS study evaluating HYMPAVZI (marstacimab) for ...
The FDA has updated labels on the top two COVID-19 vaccines to warn of a rare heart side effect, mostly seen in young men.
As a new variant that causes 'razor blade throat' spreads, the FDA updates vaccine warnings to include information on heart ...
The FDA, under Health Secretary Robert F. Kennedy Jr., has taken another step to question the safety of Covid-19 vaccines.
The Food and Drug Administration said Wednesday it was expanded existing warnings on the two leading COVID vaccines about a ...
The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results